首页> 外文OA文献 >‘ZS-MDR-TB’ versus ‘ZR-MDR-TB’: improving treatment of MDR-TB by identifying pyrazinamide susceptibility

【2h】

‘ZS-MDR-TB’ versus ‘ZR-MDR-TB’: improving treatment of MDR-TB by identifying pyrazinamide susceptibility

机译：'ZS-MDR-TB'与'ZR-MDR-TB'：通过鉴定吡嗪酰胺敏感性改善MDR-TB的治疗方法

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Ying Zhang; Kwok Chiu Chang; Chi-Chiu Leung; Wing Wai Yew; Brigitte Gicquel; Dorothy Fallows; Gilla Kaplan; Richard E Chaisson; Wenhong Zhang;
展开▼
作者单位

展开▼
年度 2012
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. ‘ZS-MDR-TB’ versus ‘ZR-MDR-TB’: improving treatment of MDR-TB by identifying pyrazinamide susceptibility [J] . Ying Zhang, Kwok Chiu Chang, Chi-Chiu Leung, Emerging microbes & infections. . 2012,第7期

机译：“ Z S -MDR-TB”与“ Z R -MDR-TB”：通过确定吡嗪酰胺敏感性，改善对MDR-TB的治疗
2. Delamanid, linezolid, levofloxacin, and pyrazinamide for the treatment of patients with fluoroquinolone-sensitive multidrug-resistant tuberculosis (Treatment Shortening of MDR-TB Using Existing and New Drugs, MDR-END): study protocol for a phase II/III, multicenter, randomized, open-label clinical trial [J] . Myungsun Lee, Jeongha Mok, Deog Kyeom Kim, Trials . 2019,第1期

机译：Delamanid，Linezolid，Levofloxacin和吡嗪酰胺用于治疗含氟喹诺酮类敏感多药结核患者（使用现有和新药物治疗MDR-TB的治疗缩短）：研究协议II / III，多中心，随机，开放标签临床试验
3. Introducing molecular testing of pyrazinamide susceptibility improves multidrug-resistant tuberculosis treatment outcomes: a prospective cohort study [J] . Sun Feng, Li Yang, Chen Yu, The European respiratory journal : . 2019,第3期

机译：介绍吡嗪酰胺敏感性的分子测试改善了多药结核治疗结果：潜在的队列研究
4. Mechanistic analysis elucidating the relationship between Lys96 mutation in Mycobacterium tuberculosis pyrazinamidase enzyme and pyrazinamide susceptibility [C] . Chakshu Vats, Jaspreet Kaur Dhanjal, Sukriti Goyal, Asia-Pacific Bioinformatics Conference . 2015

机译：机械分析阐明了结核分枝杆菌吡嗪酰胺酶和吡嗪酰胺敏感性术中Lys96突变的关系
5. Treatment of latent tuberculosis infection with isoniazid (INH) for nine months versus rifampin and pyrazinamide (RZ) for two months: A comparison of rate of liver injury in Baltimore City Chest Clinic during 1999--2001. [D] . Obiako, Emmanuel Chinasa. 2007

机译：异烟肼（INH）与利福平和吡嗪酰胺（RZ）两个月治疗潜伏性肺结核感染九个月：巴尔的摩市胸科诊所1999--2001年肝损伤率的比较。
6. ‘ZS-MDR-TB versus ‘ZR-MDR-TB: improving treatment of MDR-TB by identifying pyrazinamide susceptibility [O] . Ying Zhang, Kwok Chiu Chang, Chi-Chiu Leung, 2012

机译：ZS-MDR-TB与 ZR-MDR-TB：通过确定吡嗪酰胺敏感性来改善MDR-TB的治疗
7. Delamanid, linezolid, levofloxacin, and pyrazinamide for the treatment of patients with fluoroquinolone-sensitive multidrug-resistant tuberculosis (Treatment Shortening of MDR-TB Using Existing and New Drugs, MDR-END): study protocol for a phase II/III, multicenter, randomized, open-label clinical trial [O] . Myungsun Lee, Jeongha Mok, Deog Kyeom Kim, 2019

机译：Delamanid，Linezolid，Levofloxacin和吡嗪酰胺用于治疗含氟喹诺酮类敏感多药结核患者（使用现有和新药物治疗MDR-TB的治疗缩短）：研究协议II / III，多中心，随机，开放标签临床试验

‘ZS-MDR-TB’ versus ‘ZR-MDR-TB’: improving treatment of MDR-TB by identifying pyrazinamide susceptibility

著录项

相似文献

相关主题

期刊订阅